Syngene eyes capacity and capability expansion post-IPO
Outsourcing Pharma-21/10/2015. Syngene says it will invest in new capacity and capabilities, including a viral testing facility, as it reports strong results in its first quarter post-IPO.
ET-NOW - 03/10/2015. An exclusive interview with Kiran Mazumdar Shaw, Peter Bains and Manoj Nerurkar on Syngene's operations and journey so far at the sprawling Syngene campus.
Syngene Q2 net profit rises 31% to Rs 52 crore
Economic Times- 20/10/2015 .Syngene International, research arm of Biocon, today posted 30.69 per cent rise in its net profit at Rs 52.29 crore for the second quarter ended September 30 .